Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Insulet Corporation

< Previous 1 2 3 Next >
Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
From Insulet Corporation
Via Business Wire
Tickers PODD
Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 Years
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in Malaysia
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces CEO Transition
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports First Quarter 2022 Revenue Increase of 17% Year-Over-Year
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet’s 2021 Sustainability Report Reveals Progress on Strategy to Deliver Growth with Purpose
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Presents New Omnipod® 5 System Data for Type 1 and Type 2 Diabetes
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce First Quarter 2022 Financial Results on May 5, 2022
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Promotes Inclusivity for People with Diabetes through Nintendo® Video Game Animal Crossing™: New Horizons
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces Board Appointment of Elizabeth Weatherman and Retirement of David Lemoine
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control
From Insulet Corporation
Via Business Wire
Tickers PODD
CORRECTING and REPLACING Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2021
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Nasdaq’s 45th Investor Conference
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Honors Diabetes Awareness with Global Activities and Events
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System
From Insulet Corporation
Via Business Wire
Tickers PODD
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.